Half-year report · Q2
6856.TEDINET S100U74Z
Period2024-01-01 → 2024-06-30
Filed2024-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥142.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥290.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥131.1bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Operating income | ¥18.6bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Operating income | ¥17.8bn | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | ¥19.3bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥48.3bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥18.1bn | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥19.2bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥24.4bn | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥13.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥40.3bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥19.0bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥13.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Net income | ¥19.0bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥469.3bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥449.0bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥435.3bn | at 2023-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥165.6bn | at 2024-06-30 | Cons. | Liabilities |
| Total liabilities | ¥165.3bn | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥303.8bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥283.7bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥266.8bn | at 2023-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥134.4bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥132.8bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥134.2bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥130.6bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥127.0bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥138.8bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥10.0bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥16.7bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.6bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4.4bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥7.3bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.3bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥9.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥21.0bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥18.6bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥312.43 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥953.71 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥449.87 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥310.83 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥948.83 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥447.66 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 64.6% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.0% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.1% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E01901-000Automotive Test Systemsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥38.6bn |
| jpcrp040300-q2r_E01901-000Automotive Test Systemsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥38.6bn |
| jpcrp040300-q2r_E01901-000Automotive Test Systemsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥1.2bn |
| jpcrp040300-q2r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥16.4bn |
| jpcrp040300-q2r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥16.4bn |
| jpcrp040300-q2r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥456m |
| jpcrp040300-q2r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥11.7bn |
| jpcrp040300-q2r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥11.7bn |
| jpcrp040300-q2r_E01901-000Process And Environmental Instruments And Systemsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥162m |
| jpcrp040300-q2r_E01901-000Scientific Instruments And Systemsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥18.8bn |
| jpcrp040300-q2r_E01901-000Scientific Instruments And Systemsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥18.8bn |
| jpcrp040300-q2r_E01901-000Scientific Instruments And Systemsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥174m |
| jpcrp040300-q2r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥57.3bn |
| jpcrp040300-q2r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥57.3bn |
| jpcrp040300-q2r_E01901-000Semiconductor Instruments And Systemsreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥20.3bn |
| jpcrp040300-q2r_E01901-000Automotive Test Systemsreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥30.5bn |
| jpcrp040300-q2r_E01901-000Automotive Test Systemsreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥30.5bn |
| jpcrp040300-q2r_E01901-000Automotive Test Systemsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥2.2bn |
| jpcrp040300-q2r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥15.6bn |
| jpcrp040300-q2r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥15.6bn |
| jpcrp040300-q2r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥178m |
| jpcrp040300-q2r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥11.3bn |
| jpcrp040300-q2r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥11.3bn |
| jpcrp040300-q2r_E01901-000Process And Environmental Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥916m |
| jpcrp040300-q2r_E01901-000Scientific Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥17.4bn |
| jpcrp040300-q2r_E01901-000Scientific Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥17.4bn |
| jpcrp040300-q2r_E01901-000Scientific Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥213m |
| jpcrp040300-q2r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥56.2bn |
| jpcrp040300-q2r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥56.2bn |
| jpcrp040300-q2r_E01901-000Semiconductor Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥18.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 557
| Item | Context | Value | Unit |
|---|---|---|---|
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.1260 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 3244000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.0773 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 1682000 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0401 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 1092000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0260 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 828000 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0197 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 822000 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0196 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 770000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0184 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 715000 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0171 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 645000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0154 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 636000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0152 | |
| Number of shares held | CurrentQuarterInstant | 15723000 | |
| Shareholding ratio | CurrentQuarterInstant | 0.3748 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 280600 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 41925600 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 419256 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 27052 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 42233252 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 419256 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 280600 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 280600 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0066 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 280600 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 280600 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0066 | |
| Cash and deposits | Prior1YearInstant | 132775000000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 134399000000 | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | 71541000000 | JPY |
| Notes and accounts receivable trade and contract assets | CurrentQuarterInstant | 69568000000 | JPY |
| Short term investment securities | Prior1YearInstant | 2000000000 | JPY |
| Short term investment securities | CurrentQuarterInstant | 2005000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 35145000000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 36052000000 | JPY |
| Work in process | Prior1YearInstant | 24696000000 | JPY |
| Work in process | CurrentQuarterInstant | 29439000000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 39632000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |